Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes (Q28073309)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes
scientific article

    Statements

    14 references
    19 March 2019
    24 March 2019
    5 August 2019
    20 August 2019
    7 October 2019
    10 October 2019
    11 October 2019
    12 October 2019
    18 October 2019
    20 November 2019
    12 September 2020
    4 February 2021
    Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes (English)
    1 reference
    0 references
    10 references
    5 August 2019
    20 August 2019
    7 October 2019
    10 October 2019
    11 October 2019
    12 October 2019
    18 October 2019
    20 November 2019
    12 September 2020
    4 February 2021
    13 references
    19 March 2019
    24 March 2019
    5 August 2019
    20 August 2019
    7 October 2019
    10 October 2019
    11 October 2019
    12 October 2019
    18 October 2019
    20 November 2019
    12 September 2020
    1 reference
    5 August 2019
    1 reference
    20 August 2019
    1 reference
    7 October 2019
    1 reference
    10 October 2019
    1 reference
    11 October 2019
    1 reference
    12 October 2019
    1 reference
    18 October 2019
    1 reference
    20 November 2019
    1 reference
    12 September 2020
    0 references
    2016
    1 reference
    2846570
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit